HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: etiology and pathogenesis.
about
Managing dyslipidemia in HIV/AIDS patients: challenges and solutionsHIV-associated lipodystrophy: a review from a Brazilian perspectiveAlterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapyImpact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study
P2860
HIV lipodystrophy etiology and pathogenesis. Body composition and metabolic alterations: etiology and pathogenesis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@ast
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@en
type
label
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@ast
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@en
prefLabel
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@ast
HIV lipodystrophy etiology and ...... ns: etiology and pathogenesis.
@en
P1433
P1476
HIV lipodystrophy etiology and ...... ons: etiology and pathogenesis
@en
P2093
Donald P Kotler
P433
P577
2003-04-01T00:00:00Z